Find Onradivir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2200336-20-3, Onradivir [inn], Cze6g5g466, (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo(2.2.2)octane-2-carboxylic acid, (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)bicyclo(2.2.2)octane-2-carboxylic acid, Bicyclo(2.2.2)octane-2-carboxylic acid, 3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2s,3s)-
Molecular Formula
C22H22F2N6O2
Molecular Weight
440.4  g/mol
InChI Key
JCHDJLSIYWBAHI-ZWHBIUKWSA-N
FDA UNII
CZE6G5G466

Onradivir
ONRADIVIR is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.
1 2D Structure

Onradivir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3S)-3-[[6-cyclopropyl-5-fluoro-2-(5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
2.1.2 InChI
InChI=1S/C22H22F2N6O2/c23-12-7-13-18(29-30-19(13)25-8-12)21-27-17(11-5-6-11)15(24)20(28-21)26-16-10-3-1-9(2-4-10)14(16)22(31)32/h7-11,14,16H,1-6H2,(H,31,32)(H,25,29,30)(H,26,27,28)/t9?,10?,14-,16-/m0/s1
2.1.3 InChI Key
JCHDJLSIYWBAHI-ZWHBIUKWSA-N
2.2 Other Identifiers
2.2.1 UNII
CZE6G5G466
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2200336-20-3

2. Onradivir [inn]

3. Cze6g5g466

4. (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid

5. (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid

6. Bicyclo(2.2.2)octane-2-carboxylic Acid, 3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2s,3s)-

7. Refchem:168306

8. Unii-cze6g5g466

9. Chembl5095075

10. Schembl21128398

11. Glxc-26953

12. Ex-a12514

13. (2s,3s)-3-[[6-cyclopropyl-5-fluoro-2-(5-fluoro-2h-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic Acid

14. Da-66347

15. Hy-145586

16. Cs-0376485

2.4 Create Date
2019-07-20
3 Chemical and Physical Properties
Molecular Weight 440.4 g/mol
Molecular Formula C22H22F2N6O2
XLogP33.9
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count5
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area117
Heavy Atom Count32
Formal Charge0
Complexity721
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty